Clinical Trial Sponsors Unanimously Agree Intrinsic Imaging Core Lab Provides Exceptional Quality

Bolton, MA / San Antonio, TX — March 20, 2016 — Intrinsic Imaging, an FDA audited, ISO 9001, 13485 and 22301 certified, GAMP® 5 compliant medical imaging core lab specializing in providing services for pharmaceutical and medical device clinical trials, today announced that for the calendar period ending December 31st, 2015, the Company attained exceptional quality results in its annual customer satisfaction survey.

Intrinsic Imaging offers Sponsors a wealth of therapeutic and operational expertise in support of clinical trials for new drug applications and medical devices. Each year they request Sponsors to evaluate Intrinsic Imaging's performance in providing imaging core lab services. For each clinical trial, Sponsors evaluate Intrinsic's performance in sixteen areas grouped into four key categories. For the calendar year ending December 31st, 2015, Intrinsic Imaging's Sponsors — which include a range of both small and large biotechnology, pharmaceutical, medical device and contract research organizations — unanimously reported that Intrinsic Imaging provides exceptional quality in every aspect of its business.

"Certified by the British Standards Institute, Intrinsic Imaging's Quality Management System has the most extensive ISO certification portfolio in the industry," said Todd A. Joron, BSc., MBA, President and Chief Operating Officer. "These results demonstrate our ability to provide imaging core lab services that consistently meet both customer and regulatory requirements."